Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Daiichi Sankyo Exits Global Hybrid Biz Model, Now Focuses on Innovation
May 18, 2015
-
REGULATORY PAFSC Second Committee to Discuss Gilead’s Combination Hepatitis C Treatment on May 28
May 15, 2015
-
REGULATORY Chuikyo Reps Discuss HTA, Re-Pricing as Sovaldi Lands in Japan
May 14, 2015
-
REGULATORY Sovaldi’s 5 Million Yen Price Tag OK’d for 12-Week Regimen, Listing on May 20
May 13, 2015
-
BUSINESS Ono to Expand Cancer-Specialized Rep Force to 150 by October Aiming for Additional Indications for Opdivo
May 13, 2015
-
BUSINESS Astellas Earnings Buoyant on Xtandi, Overseas Sales Offset Japan Fall
May 12, 2015
-
REGULATORY Chuikyo to Discuss Listing of Gilead’s Sovaldi on May 13; Listing Could Take Place This Month
May 11, 2015
-
REGULATORY 10-Year Reexamination Period Possible for Repositioned Drugs under Sakigake System: Official
May 8, 2015
-
ACADEMIA MHLW-Funded Study Calls for Use-Based Development Plans for Combination Drugs
May 7, 2015
-
BUSINESS Nichi-Iko Most Favored Maker of Plavix Generics: Survey
May 1, 2015
-
BUSINESS Daiichi Sankyo Cuts FY2014 Forecasts on Write-Off Loss Tied to Zelboraf
April 30, 2015
-
REGULATORY MOF Presses for 80% Generic Share Target by FY2017
April 28, 2015
-
REGULATORY Number of Topics Discussed by PAFSC Second Committee Exceeds that of First Committee for 1st Time in 10 Years: Jiho Tally
April 28, 2015
-
REGULATORY AMED, JPMA Discussing Joint Use of Compounds, with Policy Announcement Expected in Early June: Dr Suematsu of AMED
April 27, 2015
-
BUSINESS Sumitomo Dainippon Faces Dim Prospects for Lurasidone Filing in Japan
April 27, 2015
-
REGULATORY LDP Weighs Clinical Development Infrastructure Utilizing Patient Registry
April 24, 2015
-
REGULATORY MHLW Official Jo Hints at Possible Move-Up of Generic Roadmap
April 23, 2015
-
BUSINESS Ono Seeks Lung Cancer Indication for Opdivo in Japan
April 23, 2015
-
BUSINESS Sales Rep Survey - Part 1: Decreases in Reps Prominent in Major Firms, Is Field Force Strategy at Turning Point?
April 22, 2015
-
BUSINESS Nissan Chemical Loses Livalo Patent Suits against 8 Firms
April 21, 2015
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…